3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Colonic Neoplasms
2
Cholangiocarcinoma
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Lymphoid Interstitial Pneumonia
1
Klatskin Tumor
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Epstein-Barr Virus Infections
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Anus Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Carboplatin
5
Radiotherapy
4
Radiation
3
Radiotherapy, Conformal
2
Platinum
2
Pemetrexed
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Bevacizumab
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
methoxyamine
1
lazertinib
1
durvalumab
1
capmatinib
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Metformin
1
Ipilimumab
1
Granulocyte Colony-Stimulating Factor
1
Gefitinib
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
dehydroftorafur
×
30 days
×
Clear all
No trials found.